Filing Details
- Accession Number:
- 0000899243-23-013232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-18 16:15:28
- Reporting Period:
- 2023-05-16
- Accepted Time:
- 2023-05-18 16:15:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590947 | F. Robert Werner | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-05-16 | 21,559 | $1.20 | 354,748 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- Represents a weighted average sale price. Actual sale prices ranged from $1.1993 to $1.1995 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes 5,000 shares of common stock acquired under the Invitae Corporation Employee Stock Purchase Plan on May 15, 2023 and an aggregate of 286,469 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Billionaire Hedge Funds
